HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sionov, R. V. Articles by Haupt, Y. Search for Related Content PubMed PubMed Citation Articles by Sionov, R. V. Articles by Haupt, Y. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 13, 8371-8374, March 26, 1999

COMMUNICATION
c-Abl Neutralizes the Inhibitory Effect of Mdm2 on p53

Ronit Vogt Sionov, Eli Moallem, Michael Berger, Anat Kazaz, Offer Gerlitz, Yinon Ben-Neriah, Moshe Oren^§, and Ygal Haupt

From the  Lautenberg Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, Jerusalem 91120, Israel and the ^§ Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel

Upon exposure to stress signals, the p53 tumor suppressor protein is stabilized and induces growth suppression. p53 activities are efficiently inhibited by the Mdm2 oncoprotein through an autoregulatory feedback loop. In addition, Mdm2 promotes p53 degradation, thereby terminating its growth inhibitory signal. Hence, p53 exerts its effects during the interval between p53 activation and the subsequent inhibition by Mdm2. Modulation of this interval by regulatory proteins may determine the extent and duration of p53 activity. Recent studies have shown that the c-Abl protein-tyrosine kinase binds p53 and enhances its transcriptional activity. Here we provide an explanation for the cooperation between these proteins. We demonstrate that c-Abl increases the expression level of the p53 protein. The enhanced expression is achieved by inhibiting Mdm2-mediated degradation of p53. This provides a likely mechanistic explanation for the findings that c-Abl overcomes the inhibitory effects of Mdm2 on p53-mediated transcriptional activation and apoptosis. These results suggest that c-Abl modulates the time window within which p53 remains active. The ability of c-Abl to neutralize the inhibitory effects of Mdm2 on p53 may be important for its growth inhibitory function.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Jing, M. Wang, W. Tang, T. Qi, C. Gu, S. Hao, and X. Zeng c-Abl Tyrosine Kinase Activates p21 Transcription Via Interaction with p53 J. Biochem., May 1, 2007; 141(5): 621 - 626. [Abstract] [Full Text] [PDF]

				Q. L. K. Lam, C. K. C. Lo, B.-J. Zheng, K.-H. Ko, D. G. Osmond, G. E. Wu, R. Rottapel, and L. Lu Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice Int. Immunol., March 1, 2007; 19(3): 267 - 276. [Abstract] [Full Text] [PDF]

				K. Podar, M. S. Raab, G. Tonon, M. Sattler, D. Barila, J. Zhang, Y.-T. Tai, H. Yasui, N. Raje, R. A. DePinho, et al. Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma Cancer Res., February 15, 2007; 67(4): 1680 - 1688. [Abstract] [Full Text] [PDF]

				I. Dulloo and K. Sabapathy Transactivation-dependent and -independent Regulation of p73 Stability J. Biol. Chem., August 5, 2005; 280(31): 28203 - 28214. [Abstract] [Full Text] [PDF]

				G. Wei, A. G. Li, and X. Liu Insights into Selective Activation of p53 DNA Binding by c-Abl J. Biol. Chem., April 1, 2005; 280(13): 12271 - 12278. [Abstract] [Full Text] [PDF]

				L. Gaughan, I. R. Logan, D. E. Neal, and C. N. Robson Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation Nucleic Acids Res., January 7, 2005; 33(1): 13 - 26. [Abstract] [Full Text] [PDF]

				D. Yu, E. Khan, M. A. Khaleque, J. Lee, G. Laco, G. Kohlhagen, S. Kharbanda, Y.-C. Cheng, Y. Pommier, and A. Bharti Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity J. Biol. Chem., December 10, 2004; 279(50): 51851 - 51861. [Abstract] [Full Text] [PDF]

				A. G. Granja, M. L. Nogal, C. Hurtado, J. Salas, M. L. Salas, A. L. Carrascosa, and Y. Revilla Modulation of p53 Cellular Function and Cell Death by African Swine Fever Virus J. Virol., July 1, 2004; 78(13): 7165 - 7174. [Abstract] [Full Text] [PDF]

				B. N. Chau, T.-T. Chen, Y. Y. Wan, J. DeGregori, and J. Y. J. Wang Tumor Necrosis Factor Alpha-Induced Apoptosis Requires p73 and c-ABL Activation Downstream of RB Degradation Mol. Cell. Biol., May 15, 2004; 24(10): 4438 - 4447. [Abstract] [Full Text] [PDF]

				H. Kim, N.-J. Kwak, J. Y. Lee, B. H. Choi, Y. Lim, Y. J. Ko, Y.-H. Kim, P.-W. Huh, K.-H. Lee, H. K. Rha, et al. Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53 J. Biol. Chem., February 27, 2004; 279(9): 7812 - 7818. [Abstract] [Full Text] [PDF]

				H. A. Steinman, E. Burstein, C. Lengner, J. Gosselin, G. Pihan, C. S. Duckett, and S. N. Jones An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis J. Biol. Chem., February 6, 2004; 279(6): 4877 - 4886. [Abstract] [Full Text] [PDF]

				T. Iwakuma and G. Lozano MDM2, An Introduction Mol. Cancer Res., December 1, 2003; 1(14): 993 - 1000. [Abstract] [Full Text] [PDF]

				D. W. Meek and U. Knippschild Posttranslational Modification of MDM2 Mol. Cancer Res., December 1, 2003; 1(14): 1017 - 1026. [Abstract] [Full Text] [PDF]

				M. Ben-Yehoyada, I. Ben-Dor, and Y. Shaul c-Abl Tyrosine Kinase Selectively Regulates p73 Nuclear Matrix Association J. Biol. Chem., September 5, 2003; 278(36): 34475 - 34482. [Abstract] [Full Text] [PDF]

				A. W. Goetz, H. van der Kuip, R. Maya, M. Oren, and W. E. Aulitzky Requirement for Mdm2 in the Survival Effects of Bcr-Abl and Interleukin 3 in Hematopoietic Cells Cancer Res., October 1, 2001; 61(20): 7635 - 7641. [Abstract] [Full Text] [PDF]

				R. Vogt Sionov, S. Coen, Z. Goldberg, M. Berger, B. Bercovich, Y. Ben-Neriah, A. Ciechanover, and Y. Haupt c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination Mol. Cell. Biol., September 1, 2001; 21(17): 5869 - 5878. [Abstract] [Full Text] [PDF]

				L. Bai and J. L. Merchant ZBP-89 Promotes Growth Arrest through Stabilization of p53 Mol. Cell. Biol., July 15, 2001; 21(14): 4670 - 4683. [Abstract] [Full Text] [PDF]

				N. Almog, M. Milyavsky, P. Stambolsky, A. Falcovitz, N. Goldfinger, and V. Rotter The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop Carcinogenesis, May 1, 2001; 22(5): 779 - 785. [Abstract] [Full Text] [PDF]

				M. S. Rodriguez, J. M. P. Desterro, S. Lain, D. P. Lane, and R. T. Hay Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation Mol. Cell. Biol., November 15, 2000; 20(22): 8458 - 8467. [Abstract] [Full Text]

				K. K. Khanna Cancer Risk and the ATM Gene: a Continuing Debate J Natl Cancer Inst, May 17, 2000; 92(10): 795 - 802. [Abstract] [Full Text] [PDF]

				Y. E. Whang, C. Tran, C. Henderson, R. G. Syljuasen, N. Rozengurt, W. H. McBride, and C. L. Sawyers c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency PNAS, May 9, 2000; 97(10): 5486 - 5491. [Abstract] [Full Text] [PDF]

				S. Muller, M. Berger, F. Lehembre, J.-S. Seeler, Y. Haupt, and A. Dejean c-Jun and p53 Activity Is Modulated by SUMO-1 Modification J. Biol. Chem., April 28, 2000; 275(18): 13321 - 13329. [Abstract] [Full Text] [PDF]

				S. Fang, J. P. Jensen, R. L. Ludwig, K. H. Vousden, and A. M. Weissman Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53 J. Biol. Chem., March 17, 2000; 275(12): 8945 - 8951. [Abstract] [Full Text] [PDF]

				Y. Nie, H.-H. Li, C. M. Bula, and X. Liu Stimulation of p53 DNA Binding by c-Abl Requires the p53 C Terminus and Tetramerization Mol. Cell. Biol., February 1, 2000; 20(3): 741 - 748. [Abstract] [Full Text]

				K. W. Kohn Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734. [Abstract] [Full Text]

				J. P. Godbout, J. Pesavento, M. E. Hartman, S. R. Manson, and G. G. Freund Methylglyoxal Enhances Cisplatin-induced Cytotoxicity by Activating Protein Kinase Cdelta J. Biol. Chem., January 18, 2002; 277(4): 2554 - 2561. [Abstract] [Full Text] [PDF]

				J. S. Isaacs, S.'i. Saito, and L. M. Neckers Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma J. Biol. Chem., May 18, 2001; 276(21): 18497 - 18506. [Abstract] [Full Text] [PDF]

				K. Tsuji, K. Mizumoto, T. Yamochi, I. Nishimoto, and M. Matsuoka Differential Effect of ik3-1/Cables on p53- and p73-induced Cell Death J. Biol. Chem., January 18, 2002; 277(4): 2951 - 2957. [Abstract] [Full Text] [PDF]